Last updated: 23 August 2024 at 4:12pm EST

Capital Management, L.P.Ra ... Net Worth




The estimated Net Worth of Capital Management, L.P.Ra ... is at least $384 Millón dollars as of 11 December 2023. Capital Ra owns over 1,000,000 units of iTeos Therapeutics stock worth over $307,040,124 and over the last 5 years Capital sold ITOS stock worth over $77,374,416.

Capital Ra ITOS stock SEC Form 4 insiders trading

Capital has made over 34 trades of the iTeos Therapeutics stock since 2019, according to the Form 4 filled with the SEC. Most recently Capital bought 1,000,000 units of ITOS stock worth $5,000,000 on 11 December 2023.

The largest trade Capital's ever made was buying 9,480,052 units of iTeos Therapeutics stock on 16 June 2022 worth over $20,382,112. On average, Capital trades about 580,607 units every 26 days since 2019. As of 11 December 2023 Capital still owns at least 19,202,009 units of iTeos Therapeutics stock.

You can see the complete history of Capital Ra stock trades at the bottom of the page.



Insiders trading at iTeos Therapeutics

Over the last 4 years, insiders at iTeos Therapeutics have traded over $196,492,023 worth of iTeos Therapeutics stock and bought 4,975,000 units worth $95,182,800 . The most active insiders traders include Capital Management, L.P.Ra ..., Capital Management, L.P.Kol... y Aaron I. Davis. On average, iTeos Therapeutics executives and independent directors trade stock every 12 days with the average trade being worth of $1,817,279. The most recent stock trade was executed by Matthew Gall on 12 October 2023, trading 5,000 units of ITOS stock currently worth $41,850.



What does iTeos Therapeutics do?

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2a receptor that is an open-label Phase 1/2a clinical trial in adult patients; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2a clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Cambridge, Massachusetts.



What does iTeos Therapeutics's logo look like?

iTeos Therapeutics, Inc. logo

Complete history of Capital Ra stock trades at Cidara Therapeutics Inc, Verastem Inc, Wave Life Sciences, Kala Bio, Rhythm Pharmaceuticals, scPharmaceuticals Inc, Solid Biosciences Inc, Iterum Therapeutics Plc, Orchard Therapeutics plc, Fulcrum Therapeutics Inc, Phathom Pharmaceuticals Inc, 89bio Inc, Imara Inc, Forma Therapeutics, Vaxcyte, Satsuma Pharmaceuticals, Nkarta y iTeos Therapeutics

Fecha
#
Empresa
Persona
Trans.
Transacción
Acciones Precio por acción Precio total Acciones después de Fuente
11 Dec 2023 Capital Management, L.P.Ra ...
Comprar 1,000,000 $5.00 $5,000,000
11 Dec 2023
19,202,009
16 Jun 2022 Capital Management, L.P.Ra ...
Comprar 9,480,052 $2.15 $20,382,112
16 Jun 2022
17,202,009
20 Jan 2023 Capital Management, L.P.Ra ...
Comprar 1,923,076 $13.00 $24,999,988
20 Jan 2023
11,609,704
4 Jan 2023 Capital Management, L.P.Ra ...
Comprar 180,703 $7.28 $1,315,518
4 Jan 2023
9,686,628
27 Dec 2022 Capital Management, L.P.Ra ...
Comprar 4,089 $5.99 $24,493
27 Dec 2022
9,505,925
19 Dec 2022 Capital Management, L.P.Ra ...
Comprar 98,787 $5.90 $582,843
19 Dec 2022
9,501,836
14 Dec 2022 Capital Management, L.P.Ra ...
Comprar 2,403,049 $5.44 $13,072,587
14 Dec 2022
9,403,049
3 Jan 2023 Capital Management, L.P.Ra ...
Comprar 629,297 $4.00 $2,517,188
3 Jan 2023
3,880,021
8 Dec 2022 Capital Management, L.P.Ra ...
Comprar 29,899 $3.87 $115,709
8 Dec 2022
3,250,724
20 Oct 2022 Capital Management, L.P.Ra ...
Comprar 85,902 $3.92 $336,736
20 Oct 2022
3,220,825
17 Oct 2022 Capital Management, L.P.Ra ...
Comprar 506,197 $3.68 $1,862,805
17 Oct 2022
3,134,923
16 Mar 2020 Capital Management, L.P.Ra ...
Comprar 625,000 $16.00 $10,000,000
16 Mar 2020
1,454,348
26 May 2022 Capital Management, L.P.Ra ...
Venta 1,005,686 $0.36 $362,047
26 May 2022
7,039,613
23 May 2022 Capital Management, L.P.Ra ...
Venta 2,829,314 $0.53 $1,499,536
23 May 2022
8,045,299
2 Jun 2021 Capital Management, L.P.Ra ...
Comprar 22,138 $18.77 $415,530
2 Jun 2021
4,965,769
26 May 2021 Capital Management, L.P.Ra ...
Comprar 207,417 $18.60 $3,857,956
26 May 2021
4,943,631
17 Sep 2020 Capital Management, L.P.Ra ...
Comprar 1,300,000 $28.00 $36,400,000
17 Sep 2020
4,736,214
8 Jul 2020 Capital Management, L.P.Ra ...
Comprar 275,000 $27.50 $7,562,500
8 Jul 2020
3,436,214
11 Nov 2019 Capital Management, L.P.Ra ...
Comprar 1,500,000 $16.00 $24,000,000
11 Nov 2019
1,500,000
19 Mar 2021 Capital Management, L.P.Ra ...
Comprar 2,206,685 $5.75 $12,688,439
19 Mar 2021
10,916,567
12 Mar 2021 Capital Management, L.P.Ra ...
Venta 150,057 $7.08 $1,062,404
12 Mar 2021
2,727,446
14 Feb 2020 Capital Management, L.P.Ra ...
Comprar 271,993 $8.20 $2,230,343
14 Feb 2020
3,247,005
11 Mar 2021 Capital Management, L.P.Ra ...
Venta 710,000 $43.75 $31,062,500
11 Mar 2021
3,115,008
1 Apr 2020 Capital Management, L.P.Ra ...
Comprar 117,600 $24.86 $2,923,536
1 Apr 2020
3,825,008
27 Mar 2020 Capital Management, L.P.Ra ...
Comprar 60,600 $24.58 $1,489,548
27 Mar 2020
3,707,408
26 Feb 2021 Capital Management, L.P.Ra ...
Comprar 1,232,394 $5.68 $6,999,998
26 Feb 2021
5,155,854
2 Dec 2020 Capital Management, L.P.Ra ...
Venta 238,543 $29.47 $7,029,862
2 Dec 2020
4,360,860
30 Jun 2020 Capital Management, L.P.Ra ...
Venta 131,581 $22.06 $2,902,677
30 Jun 2020
5,140,408
25 Jun 2020 Capital Management, L.P.Ra ...
Venta 150,323 $23.05 $3,464,945
25 Jun 2020
5,271,989
7 Oct 2020 Capital Management, L.P.Ra ...
Venta 266,258 $50.78 $13,520,581
7 Oct 2020
5,001,593
29 Sep 2020 Capital Management, L.P.Ra ...
Venta 221,330 $50.81 $11,245,777
29 Sep 2020
0
10 Aug 2020 Capital Management, L.P.Ra ...
Comprar 769,017 $4.63 $3,560,549
10 Aug 2020
9,880,865
25 Jun 2020 Capital Management, L.P.Ra ...
Venta 1,161,300 $1.91 $2,218,083
25 Jun 2020
16,142,051
27 Apr 2020 Capital Management, L.P.Ra ...
Venta 1,301,300 $2.31 $3,006,003
27 Apr 2020
17,303,351


iTeos Therapeutics executives and stock owners

iTeos Therapeutics executives and other stock owners filed with the SEC include: